P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma

• Mia Lohmann,
• Iris Buchberger,
• Anna Beielstein,
• Başak Kaçar,
• Julia Mattlener,
• Marieke Nill,
• Zhiyuan Shi,
• Jan-Michel Heger,
• Christian Pallasch,
• Roland Ullrich,
• Sven Borchmann

Affiliations

Mia Lohmann

1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany

Iris Buchberger

1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany

Anna Beielstein

1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany

Başak Kaçar

1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany

Julia Mattlener

1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany

Marieke Nill

1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany

Zhiyuan Shi

1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany

Jan-Michel Heger

1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany

Christian Pallasch

1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany

Roland Ullrich

1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany

Sven Borchmann

1 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany